Arpa Garay

Insider Reports History

Location
Kenilworth, NJ
Signature
/s/ James Dillon, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arpa Garay:

Company Role Class Num Shares Value Price $ Report Date Ownership
Moderna, Inc. Chief Commercial Officer Restricted Stock Units 11,405 $1,140,614 $100.01 05 Dec 2023 Direct
Moderna, Inc. Chief Commercial Officer Common Stock 3,690 $383,391 $103.90 06 Dec 2023 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Common Stock 2,109 $251,878 $119.43 04 May 2022 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Restricted Stock Unit 1,819 $234,287 $128.80 04 May 2022 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Stock Option (Right to Buy) 21,359 03 May 2022 Direct
Moderna, Inc. Chief Commercial Officer Stock Option (Right to Buy) 20,040 28 Feb 2023 Direct

Insider Reports Filed by Arpa Garay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRNA Moderna, Inc. 05 Dec 2023 3 -$44,182 4 Chief Commercial Officer 07 Dec 2023, 16:21
MRNA Moderna, Inc. 05 Sep 2023 3 -$62,219 4 Chief Commercial Officer 07 Sep 2023, 17:46
MRNA Moderna, Inc. 05 Jun 2023 3 -$287,972 4 Chief Commercial Officer 07 Jun 2023, 16:05
MRNA Moderna, Inc. 28 Feb 2023 2 $0 4 Chief Commercial Officer 02 Mar 2023, 16:27
MRNA Moderna, Inc. 28 Jun 2022 0 $0 3 Chief Commercial Officer 29 Jun 2022, 16:04
MRK Merck & Co., Inc. 03 May 2022 4 +$56,441 4 SVP Human Health Global Mktg. 05 May 2022, 17:24
MRK Merck & Co., Inc. 03 May 2022 3 +$48,383 4 SVP Human Health Global Mktg. 04 May 2022, 16:44
MRK Merck & Co., Inc. 01 May 2022 3 +$54,899 4 SVP Human Health Global Mktg. 03 May 2022, 16:11
MRK Merck & Co., Inc. 28 Feb 2022 0 $0 3 SVP Human Health Global Mktg. 10 Mar 2022, 18:15